Improving the Efficiency of Clinical Pharmacology Studies

被引：2
|
作者：
Polasek, Thomas M. M. [1 ,2 ]
Schuck, Virna [3 ]
机构：
[1] Certara, 100 Overlook Ctr,Suite 101, Princeton, NJ 08540 USA
[2] Monash Univ, Ctr Med Use & Safety, Melbourne, Vic, Australia
[3] Ribon Therapeut Inc, Cambridge, MA USA
来源：
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT | 2023年 / 12卷 / 08期
关键词：
clinical pharmacology; drug development; first-in-human; model-informed drug development; new drugs;
D O I：
10.1002/cpdd.1274
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：771 / 774
页数：4
相关论文
共 50 条
  • [1] Commentary on Improving the Efficiency of Clinical Pharmacology Studies
    Fossler, Michael J.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (08): : 775 - 778
  • [2] Clinical Pharmacology Studies in Critically Ill Children
    Thakkar, Nilay
    Salerno, Sara
    Hornik, Christoph P.
    Gonzalez, Daniel
    PHARMACEUTICAL RESEARCH, 2017, 34 (01) : 7 - 24
  • [3] Clinical Pharmacology Studies in Critically Ill Children
    Nilay Thakkar
    Sara Salerno
    Christoph P. Hornik
    Daniel Gonzalez
    Pharmaceutical Research, 2017, 34 : 7 - 24
  • [4] Clinical pharmacology and clinical trials in Japan
    Ebihara, A
    Takahashi, K
    Ikemoto, F
    Yamamoto, K
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1996, 74 (08): : 479 - 486
  • [5] Special Populations in Clinical Pharmacology Studies: Evolving Challenges
    Smith, William B.
    Alcorn, Harry, Jr.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (03) : 285 - 287
  • [6] Special Populations in Clinical Pharmacology Studies: Evolving Challenges
    William B. Smith
    Harry Alcorn
    Therapeutic Innovation & Regulatory Science, 2017, 51 : 285 - 287
  • [7] Clinical pharmacology-how it shapes the drug development journey
    Kruse, Matthias
    Stankeviciute, Simona
    Perry, Sheryl
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 81 (04) : 597 - 604
  • [8] INTERDEPARTMENTAL GRADUATE STUDIES IN CLINICAL-PHARMACOLOGY - A PRACTICAL MODEL
    JALLAD, NS
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1994, 32 (11) : 589 - 593
  • [9] Pharmacogenomic data submissions to the FDA:: clinical pharmacology case studies
    Ruaño, G
    Collins, JM
    Dorner, AJ
    Wang, SJ
    Guerciolini, R
    Huang, SM
    PHARMACOGENOMICS, 2004, 5 (05) : 513 - 517
  • [10] Clinical pharmacology: a paradigm for individualized medicine
    Waldman, Scott A.
    Kraft, Walter K.
    Nelson, Timothy J.
    Terzic, Andre
    BIOMARKERS IN MEDICINE, 2009, 3 (06) : 679 - 684
12345